Use this before a trial screen, clinic deposit, retreat payment or facilitator agreement. It does not declare an offer safe. It helps you find the person, document and emergency plan that must carry the claim.
Regulatory and safety sources checked August 28, 2026. Licensed-prescriber and California legal review are pending; no review badge is claimed.
The answer changes which proof matters. Your choice stays on this page and is not saved.
Ask for the NCT number. Open the ClinicalTrials.gov record yourself. Confirm the California location, posted status, age range, study contact, randomization, costs, alternatives and injury language. Registration is not FDA approval, and the study team still decides eligibility.
Open the California trial desk →Spravato is esketamine with specific FDA-approved adult depression uses and a supervised safety program. Psychiatric use of FDA-approved ketamine injection is off-label. A compounded ketamine product is not FDA-approved. Record the prescriber, product, route, monitoring, pharmacy and whole-course price.
Use the ketamine clinic checklist →This official-source review, checked August 28, 2026, identified no statewide California service-center or facilitator licensing system for psilocybin, MDMA, LSD, DMT, ibogaine, ayahuasca, mescaline or methylone treatment. A therapist licence, training certificate, local enforcement policy or religious claim is not FDA approval. Ask for the exact claimed authority and independent professional licence before money changes hands; California legal review of this wording remains pending.
Compare the California treatment lanes →Oregon has a licensed psilocybin-services system with required preparation, consent, safety, transportation and follow-up steps. That system is not California medical treatment and does not make psilocybin FDA-approved. Verify the out-of-state licence in that state’s official directory.
Read Oregon’s official service rules ↗ →Get four things in writing: the exact drug and route; whether this is FDA-approved care, off-label use of an approved drug, a compounded product that is not FDA-approved, registered research or another service; the accountable person’s professional licence; and the complete price through follow-up. If the seller cannot name the lane, the experience should not be used to blur it.
Work through the questions below →FDA’s 2026 guidance recommends two session monitors for psychedelic drug trials, a qualified lead, rapid physician availability, informed consent about prolonged changes in judgment and suggestibility, and plans for monitoring and safe discharge. Those are federal research recommendations. They are not a California consumer-service licence or proof that a non-research offer is lawful.
Oregon separately requires preparation, informed consent, a bill of rights, transportation and safety planning in its licensed psilocybin system. Oregon’s rules are a useful list of questions. They are not California rules.
Nothing you check or type is sent to TherapyCalifornia or placed in site storage. Print a blank copy, or work on the page while the tab remains open.
The first protection is ordinary language. Write down the answer before the sales call becomes a story.
The person responsible for medical safety needs the medicines, health history and psychiatric history that could change the plan.
A nearby emergency room is not an onsite plan. Ask about people, observation, equipment and the point when you are considered ready to leave.
FDA’s research guidance names increased vulnerability and suggestibility. Consent must survive the moment when saying no becomes harder.
Put research costs, clinical charges and optional services on separate lines. A promise of transformation is not an invoice.
Leaving, driving, sleep, symptom change and follow-up belong in the plan before the drug is given.
A pause is not a remote verdict that a person or program is unsafe. It is a reason to get a specific written answer before pressure, money or an altered state makes the question harder to ask.
Who reviews psychiatric history, medicines, blood pressure, expected duration, observation and driving—and what evidence applies to this exact compound and condition?
None has an FDA-approved mental-health use. This August 28, 2026 official-source review identified no statewide California licensed-treatment system for these substances.
Who reviews heart and blood-pressure risk, temperature, hydration and medicines—including MAO inhibitors—and who manages an acute reaction?
Both remain investigational. Methylone is not MDMA by another name.
What ECG, QT, electrolyte, medication and delayed cardiac-monitoring protocol is used, and where is the regulated study record?
California’s recruiting ibogaine record is observational and does not provide ibogaine.
Which product and route, which indication, approved or off-label, compounded or manufactured, how are blood pressure, sedation, breathing and discharge handled?
Spravato has specific FDA-approved psychiatric uses. Psychiatric use of FDA-approved ketamine injection is off-label; a compounded ketamine product is not FDA-approved.
If you may act on suicidal thoughts, call or text 988. For chest pain, trouble breathing, seizure, loss of consciousness, extreme agitation, dangerous confusion or immediate danger after taking a substance, call 911.
A trial contact, facilitator or integration appointment is not an emergency service.
For research, ask the study team and the independent participant-rights contact named in consent. For medication, use your own prescriber and verify the treating professional’s California licence. For psychotherapy before or after an experience, verify the therapist’s licence and ask what care they provide without supplying or administering a drug.
Educational decision support, not medical advice, legal advice, individualized screening, a safety clearance, research recruitment or a determination about a particular business. Do not start, stop or taper medicine from this page. Sources checked August 28, 2026. Licensed-prescriber and California legal review pending. Paid for by participating therapists. Inclusion is computed, never purchased. No ads. No data sold.